360+ cANCeR InFOrMATiON SHEETS fOR YoU BIOLOGICAL THERAPIES Aldesleukin (Proleukin ) Bevacizumab (Avastin®) Bortezomib (Velcade®) Cancer vaccines Cetuximab (Erbitux®) Dasatinib (Sprycel®) Erlotinib (Tarceva) Erythropoietins G-CSF (granulocyte-colony stimulating factor) Gefitinib (Iressa®) Gemtuzumab ozogamicin (Mylotarg®) Imatinib (Glivec®) Interferon alpha (IntronA®, Roferon-A®) Iodine131 tositumomab (Bexxar®) Ipilimumab (YERVOY®) Lapatinib (Tyverb®) Lenalidomide (Revlimid®) Nilotinib (TASIGNA®) Panitumumab (Vectibix®) Pazopanib (Votrient®) Rituximab (Mabthera®) Sorafenib (Nexavar®) Sunitinib (Sutent®) Temsirolimus (Torisel®) Thalidomide Trastuzumab (Herceptin®) Zevalin® (90Y-Ibritumomab tiuxetan) ® BRAIN AND SPINAL TUMOURS Acoustic neuroma Astrocytic tumours Chordoma Ependymoma Haemangioblastoma Making a radiotherapy mask Malignant spinal cord compression (MSCC) Medulloblastoma Meningioma Mixed gliomas Oligodendroglioma Pineal-region tumours Pituitary gland tumours Primary CNS lymphoma Secondary brain tumours Spinal cord tumours BREAST CANCER Breast cancer treatment and menopausal symptoms Inflammatory breast cancer Lobular carcinoma in situ (LCIS) Paget’s disease of the breast Breast calcifications Breast screening for women with a family history of breast cancer Ovarian ablation and breast cancer HER2 positive breast cancer Triple negative breast cancer Phyllodes tumour of the breast Tubular breast cancer CHEMOTHERAPY DRUGS Abraxane® Amsacrine (Amsidine®) Azacitidine (Vidaza®) Bendamustine (Levact®) Bleomycin Busulfan (Busilvex®, Myleran®) Cabazitaxel Capecitabine (Xeloda®) Carboplatin Carmustine (BiCNU®) Chlorambucil (Leukeran®) Cisplatin Cladribine (Leustat®, LITAK®) Clofarabine (Evoltra®) Crisantaspase (Erwinase®) Cyclophosphamide Cytarabine Dacarbazine (DTIC) Dactinomycin (Cosmegen Lyovac®) Daunorubicin Docetaxel (Taxotere®) Doxorubicin Epirubicin (Pharmorubicin®) Etoposide (VP-16, Etopophos®, Vepesid®) Fludarabine (Fludara®) Fluorouracil (5FU) Gemcitabine (Gemzar®) Gliadel® implants (Carmustine) Hydroxycarbamide (Hydrea®) Idarubicin (Zavedos®) Ifosfamide (Mitoxana®) Irinotecan (Campto®) Leucovorin (folinic acid) Liposomal daunorubicin (DuanoXome®) Liposomal doxorubicin (Caelyx®, Myocet®) Lomustine Melphalan (Alkeran®) Mercaptopurine (Puri-Nethol®) Mesna (Uromitxan®) Methotrexate Mitomycin Mitotane (Lysodren®) Mitoxantrone Oxaliplatin (Eloxatin®) Paclitaxel (Taxol®) Pemetrexed (Alimta®) Pentostatin (Nipent®) Procarbazine Raltitrexed (Tomudex®) Satraplatin Streptozocin (Zanosar®) Tegafur-uracil (Uftoral®) Temozolomide (Temodal®) Thiotepa Tioguanine (Lanvis®) Topotecan (Hycamtin®) Trabectedin (Yondelis®) Treosulfan Vinblastine (Velbe®) Vincristine (Oncovin®) Vindesine (Eldisine®) Vinorelbine (Navelbine®) CHILDREN’S CANCERS Acute lymphoblastic leukaemia (ALL) in children Acute myeloid leukaemia (AML) in children Brain tumours in children Ewing’s sarcoma in children Germ cell tumours in children Hodgkin lymphoma in children Langerhans’ cell histiocytosis (LCH) in children Liver tumours in children Neuroblastoma in children Non-Hodgkin’s lymphoma (NHL) in children Osteosarcoma in children Radiotherapy for children with cancer in the abdomen (tummy) and pelvis Radiotherapy for children with cancer in the chest area Radiotherapy for children with head and neck cancers Rare cancers in children Retinoblastoma in children Rhabdomyosarcoma in children Wilms’ tumour (nephroblastoma) in children COMBINATION CHEMOTHERAPY REGIMENS ABVD chemotherapy AC chemotherapy BEAM chemotherapy BEP chemotherapy CAF chemotherapy Capecitabine and docetaxol chemotherapy Carbo MV chemotherapy Carboplatin and etoposide chemotherapy CAV chemotherapy ChlVPP chemotherapy CHOP chemotherapy Cisplatin and flouroroucil (5FU) chemotherapy Cisplatin and topotecan chemotherapy CMF chemotherapy CTD chemotherapy CVP chemotherapy De Gramont and modified de Gramont chemotherapy DHAP chemotherapy Docetaxel (Taxotere®) and carboplatin chemotherapy Docetaxel (Taxotere®) and cisplatin chemotherapy Doxorubicin and ifosfamide chemotherapy EC chemotherapy ECF chemotherapy E-CMF (Epi-CMF) chemotherapy ECX chemotherapy ELF chemotherapy EOX chemotherapy ESHAP chemotherapy Etoposide and cisplatin chemotherapy (EP/PE) FCR chemotherapy FEC chemotherapy FEC-T chemotherapy FOLFIRINOX chemotherapy GemCarbo chemotherapy Gemcitabine and capecitabine (GemCap) chemotherapy Gemcitabine and cisplatin chemotherapy GemTaxol chemotherapy Hyper-CVAD chemotherapy ICE and R-ICE chemotherapy for lymphoma Irinotecan and cetuximab Irinotecan with fluorouracil (5FU) and folinic acid Mayo chemotherapy MIC chemotherapy MM chemotherapy MMM chemotherapy MPT chemotherapy MVAC chemotherapy MVP chemotherapy Oxaliplatin with fluorouracil (5FU) and folinic acid chemotherapy (FOLFOX or OxMdG) Oxaliplatin and capecitabine (Xeloda®) chemotherapy Paclitaxel and carboplatin chemotherapy (Taxol/Carbo) PCV chemotherapy Pemetrexed and cisplatin chemotherapy PMitCEBO chemotherapy POMB/ACE chemotherapy R-CHOP chemotherapy R-CVP chemotherapy R-DHAP chemotherapy R-ESHAP chemotherapy TAC chemotherapy TC chemotherapy TIP chemotherapy VAD chemotherapy Vinorelbine and carboplatin chemotherapy Vinorelbine and cisplatin (VP) chemotherapy DIGESTIVE SYSTEM CANCERS Anal cancer Bile duct cancer (cholangiocarcinoma) Gall bladder cancer Gastrointestinal stromal tumours (GISTs) Neuroendocrine tumours (NETs) Small bowel cancer GIVING CHEMOTHERAPY Central lines (skin-tunnelled venous catheters) Implantable ports Lumbar puncture and intrathecal chemotherapy Mesna (Uromitexan®) PICC lines (peripherally inserted central catheters) Rasburicase (Fasturtec®) Scalp cooling Haematological conditions Anaplastic large cell lymphoma Burkitt lymphoma Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma Essential thrombocythaemia (ET) Follicular lymphoma Hairy cell leukaemia HIV-related lymphoma Lymphoblastic lymphoma MALT lymphoma Mantle cell lymphoma Mediastinal large B-cell lymphoma (MLBCL) MGUS (monoclonal gammopathy of unknown significance) Myelofibrosis (MF) Nodal marginal zone lymphoma (nodal MZL) Polycythaemia vera (PV) Small lymphocytic lymphoma The myelodysplastic syndromes (MDS) Thyroid lymphoma Waldenström macroglobulinaemia Hormonal therapies Abiraterone acetate (Zytiga®) Anastrozole (Arimidex®) Bicalutamide (Casodex®) Buserelin (Suprefact®) Cyproterone acetate (Cyprostat®) Degarelix (Firmagon®) Diethylstilbestrol (Stilboestrol) Exemestane (Aromasin®) Flutamide (Drogenil®) Fulvestrant (Faslodex) Goserelin for breast cancer (Zoladex®) Goserelin for prostate cancer (Zoladex®, Zoladex LA®, Novgos®) Letrozole (Femara®) Leuprorelin acetate (Prostap® SR DCS, Prostap® 3 DCS) Medroxyprogesterone acetate (Provera®) Megestrol acetate (Megace®) Tamoxifen Toremifene (Fareston®) Triptorelin (Decapeptyl® SR, Gonapeptyl Depot®) LIVING WITH CANCER Advance decisions Ascites Avoiding infection when you have reduced immunity Blood transfusions Cancer fistula Cardiopulmonary resuscitation (CPR) for people with cancer Care of your pets when you have cancer Childcare when a parent or carer has cancer Clinical negligence Controlling nausea and vomiting (anti-emetic therapy) Dietary problems after surgery for stomach cancer Difficulty sleeping (insomnia) Fungating cancer wounds (malignant wounds) Getting a second opinion Making a complaint Memory box Mild cognitive impairment Mouth care during chemotherapy Mouth care during radiotherapy – coping with a dry mouth (xerostomia) Nutritional support (artificial feeding) Overseas visitors – a guide to free hospital treatment in the UK Peripheral neuropathy Platelet transfusions Pleural effusion Prostate cancer and hormonal symptoms Skin grafts for skin cancer Superior vena cava obstruction (SVCO) What you can do if a drug or treatment isn’t available Other specific/secondary cancers Anorectal melanoma Fallopian tube cancer Germ cell tumours of the ovary (ovarian teratoma) Melanoma of the eye (ocular melanoma) Mouth cancer Multiple endocrine neoplasia 1 (MEN1) Multiple endocrine neoplasia 2 (MEN2) Nasopharyngeal cancer Oropharyngeal cancer Paranasal sinus cancer Penile cancer (cancer of the penis) Primary peritoneal cancer (PPC) in women Pseudomyxoma peritoneiw Salivary gland cancer Secondary cancer in the lung Secondary cancer in the lymph nodes Thymoma and thymic carcinoma Tracheal cancer Tumours of the adrenal glands Tumours of the parathyroid glands Ureter and renal pelvis cancer Vaginal cancer Other treatments CHART radiotherapy for non-small cell lung cancer (NSCLC) Clodronate (Bonefos®, Clasteon®, Loron®) Having a hysterectomy Hyperbaric oxygen therapy Ibandronic acid (Bondronat®) Intensity Modulated Radiation Therapy (IMRT) Isolated limb perfusion (ILP) Nephrostomy Pamidronate (Aredia®) Pelvic exenteration for men Pelvic exenteration for women Photodynamic therapy (PDT) Plasma exchange (plasmapheresis) Prophylactic cranial radiotherapy (PCR) Radiofrequency ablation Selective Internal Radiotherapy Treatment (SIRT) Steroids Surgery Zoledronic acid (Zometa®) Pre-cancerous conditions Barrett’s oesophagus Bowen’s disease Familial adenomatous polyposis (FAP) HPV and cancer HPV vaccines (to prevent cancer) Lynch Syndrome (also known as Hereditary non-polyposis colorectal cancer [HNPCC]) Vaginal intra-epithelial neoplasia (VAIN) Vulval intra-epithelial neoplasia (VIN) Vulval lichen sclerosus and lichen planus Sarcomas Chondrosarcoma Ewing’s sarcoma of the bone Kaposi’s sarcoma Leiomyosarcoma Osteosarcoma Rhabdomyosarcoma TRANSLATIONS Breast cancer (in Bengali, Gujarati, Hindi, Punjabi and Urdu) Chemotherapy (in Bengali, Gujarati, Hindi, Polish, Punjabi, Russian, Traditional Chinese and Urdu) Radiotherapy (in Bengali, Gujarati, Hindi, Polish, Punjabi, Russian, Traditional Chinese and Urdu) Surgery (in Bengali, Gujarati, Hindi, Polish, Punjabi, Russian, Traditional Chinese and Urdu) Got any feedback for us? Tell us what you think by emailing cancerinformationteam@ macmillan.org.uk
© Copyright 2025 ExpyDoc